• editor@pphm.life
  • Accurate | Trusted | Reliable
#1 Evidenced-based Health News in Malaysia
PP Health Malaysia Banner PPHM

Singularity Connect and IJN Research Sign MoU to Advance Agentic AI in Healthcare

Key Insights

Singularity Connect Sdn Bhd, a Malaysian technology group focused on the development, application and commercialisation of artificial intelligence (AI), has entered into a Memorandum of Understanding (MoU) with IJN Research Sdn Bhd, the research arm within the Institut Jantung Negara (IJN) ecosystem.

The collaboration will explore the development and commercialisation of AI applications for healthcare, with an initial focus on supporting advancements in integrated cardiovascular and thoracic care.

The MoU was exchanged at the National Innovation and Commercialisation Expo 2026 (NICE 2026), held at the Kuala Lumpur Convention Centre.

Through the partnership, Singularity Connect will contribute its Agentic AI capabilities, while IJN Research will provide clinical expertise, research capabilities and access to a healthcare innovation ecosystem. Together, the organisations will explore an outcome-focused AI platform governed responsibly and designed to support healthcare professionals, clinical research and patient outcomes.

The parties will also consider bringing together multidisciplinary teams comprising medical professionals, developers, data scientists, statisticians, bioinformaticians and other relevant specialists to support healthcare-focused AI development.

Where appropriate, Singularity Connect and IJN Research may also work with the Malaysian Research Accelerator for Technology and Innovation (MRANTI) and other innovation partners to support the journey from research and technology development to practical implementation and commercialisation.

The collaboration comes as Malaysia continues to increase the adoption and commercialisation of emerging technologies across priority industries. NICE 2026, organised by the Ministry of Science, Technology and Innovation (MOSTI) and driven by MRANTI, convenes stakeholders from across Malaysia’s innovation ecosystem under the theme, “Mission to Market. Malaysia to the World.”

Ahmad Fauzi bin Ali, Group Chief Executive Officer of Singularity Connect Sdn Bhd, said:

“Healthcare is one of the areas where artificial intelligence has the potential to create meaningful and measurable impact, but technology alone is not enough. It needs to be developed alongside deep clinical expertise, real-world healthcare understanding and strong research capabilities”

“Our collaboration with IJN Research brings these elements together. Through this partnership, we aim to demonstrate how Agentic AI can be applied responsibly and practically to support healthcare professionals, research and ultimately better health outcomes. It also reflects our broader focus at Singularity Connect on putting AI to work in industries where it can create real value.”

Prof Dato’ Dr Suhaini bin Kadiman, Chief Research & Innovation Officer of IJN Research Sdn Bhd, said:

“Healthcare is fundamentally human, and AI should strengthen — not replace — that human connection. At IJN Research, we believe the future lies in combining clinical expertise and human judgement with responsible, explainable AI to deliver better decisions and better patient outcomes”

“IJN’s strong and well-structured clinical data ecosystem, integrated digital workflows and recent achievement of HIMSS EMRAM Stage 7 — the highest level of digital maturity — provide a strong foundation for this ambition”

“Through our collaboration with Singularity Connect, we aim to harness Agentic AI to transform trusted clinical data into actionable intelligence while keeping clinicians and patients at the centre of every innovation. Ultimately, we seek to develop home-grown, human-centred healthcare AI that can be clinically validated in Malaysia and scaled across the region and beyond.”

The MoU establishes a framework for the two organisations to explore potential areas of cooperation. Specific programmes, projects and commercial initiatives will be developed and agreed by both parties in due course.

For Singularity Connect, the collaboration is part of its wider strategy to support the practical adoption and commercialisation of AI by combining technology with industry expertise and real-world applications.

Disclaimer: Editorial content on this site is for general information only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider with any questions about your health. While we take care to ensure accuracy, we make no guarantees and accept no responsibility for any errors, omissions, outdated information or any consequences arising from use of this site. Views expressed in articles, interviews and features are those of the authors or contributors and do not  necessarily reflect the views of the publisher. References to, or advertisements for, products or services do not constitute endorsements, and we do not guarantee their quality, safety or effectiveness. You can read our editorial policy.

Discover more from PP Health Malaysia

Subscribe now to keep reading and get access to the full archive.

Continue reading